Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-25 @ 4:50 AM
NCT ID:
NCT06073418
Eligibility Criteria:
Inclusion Criteria:
* Patients with surgically removed early stage (I-IIIa) hormone receptor-positive or hormone receptor negative breast cancer. Patients with hormone receptor-positive breast cancer can be in treatment with endocrine therapy; patients with hormone receptor-negative tumors have to be in follow-up. Concomitant use of targeted therapies with anti-hormonal agents is allowed only in adjuvant setting
* Female patients ≥18 years of age.
* Written informed consent must be obtained before any study-related assessment is performed
Exclusion Criteria:
* Patients with advanced/metastatic breast cancer.
* Patients with early breast cancer receiving (neo)adjuvant chemotherapy or anti-HER2 agents
* Patients receiving active treatment for secondary primary tumors (excluding basal cell carcinoma or in situ neoplasias)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06073418
Study Brief:
Protocol Section:
NCT06073418